Community-Acquired Infections clinical trials
The registry lists 37 studies for Community-Acquired Infections across more than 10 countries. 5 are recruiting or about to start. 19 of them are mainly about Community-Acquired Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29. Counting its narrower condition Community-Acquired Pneumonia too: 355 studies, 80 open.
Get an email when these change. Save the Community-Acquired Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
GlaxoSmithKline (4) · Wyeth is now a wholly owned subsidiary of Pfizer (4) · Henan University of Traditional Chinese Medicine (2) · BreathTec Biomedical Inc. (1) · Pfizer (1) · Aga Khan University (1) · Central Hospital Saint Quentin (1) · Vestre Viken Hospital Trust (1)
What is being tested here
Drugs under test in Community-Acquired Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4, phase 3 first
- Dec 2026Targeting Vascular INflammation in Patients With Community-Acquired Pneumonia · Phase 3 · Ottawa Heart Institute Research Corporation
- Nov 2026Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia · Assiut University
- Nov 2026ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly Patients · Joan Sabater-Riera
- Apr 2027Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine · Henan University of Traditional Chinese Medicine
Who these studies take
Of the 3 Community-Acquired Infections studies recruiting now, 3 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (33%) | 1 (33%) |
| 18 | 3 (100%) | 3 (100%) |
| 30 | 3 (100%) | 3 (100%) |
| 40 | 3 (100%) | 3 (100%) |
| 50 | 3 (100%) | 3 (100%) |
| 65 | 3 (100%) | 3 (100%) |
| 75 | 3 (100%) | 3 (100%) |
| 85 | 3 (100%) | 3 (100%) |
Across all 37 studies, recruiting or not: 27% stop at 75 or younger and 24% at 65; 30% take children; 0% are for women only and 5% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 14, 2026.
Stopped1
- Integrated Clinical Decision Support for Empiric Antibiotic Selection in SepsisTerminatedOct 19, 2026NCT06103500
Studies
Recruiting first, then most recently updated. Showing 37 of 37. search them.
- Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired PneumoniaRecruitingNCT06996834Not applicable1 country
- ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly PatientsEnrolling by invitationNCT070702846 countries
- Targeting Vascular INflammation in Patients With Community-Acquired PneumoniaRecruitingNCT06710080Phase 31 country
- Clinical and Ecological Impact of a Primary Care Antimicrobial Stewardship Program Based on Telematic Educational Interviews (TELÉMACO Trial)RecruitingNCT06706583Not applicable1 country
- Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese MedicineNot yet recruitingNCT066136591 country
- Community-associated Highly-Resistant EnterobacteralesCompletedNCT039249341 country
- Integrated Clinical Decision Support for Empiric Antibiotic Selection in SepsisTerminatedNCT06103500Not applicable1 country
- Sepsis-3 Study in Northeast ThailandCompletedNCT033794021 country
- Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer CandidatesCompletedNCT00475930Not applicable1 country
- Community Acquired Bacteremic Syndromes in Young Nigerian ChildrenCompletedNCT029467751 country
- Avoidable Readmissions For Patients Hospitalized With Community-Acquired PneumoniaCompletedNCT028332591 country
- Community-based RSV Surveillance in Infant Mortality: Minimally Invasive Tissue Sampling Study in Karachi, PakistanStatus unknownNCT050475491 country
- Management of Parapneumonic Pleurisy Guided by an Early Pleural UltrasoundCompletedNCT043487341 country
- Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)CompletedNCT02531438Phase 325 countries
- Optimization Management Study of Community Urinary Tract Infections SpectrumCompletedNCT03655548
- Infection Detection by Breath AnalysisWithdrawnNCT02981550
- An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult SubjectsCompletedNCT01267968Phase 11 country
- GSK2251052 Mass Balance in Healthy Adult SubjectsCompletedNCT01475695Phase 11 country
- A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase StudyTerminatedNCT01702350Phase 11 country
- A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy VolunteersTerminatedNCT01495065Phase 11 country
- Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe PneumoniaStatus unknownNCT03185923Phase 31 country
- Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data AnalysisStatus unknownNCT030932201 country
- CA-MRSA Infection in China: Epidemiology, Molecular Characteristics, Treatment, and OutcomeStatus unknownNCT030644641 country
- Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and PrognosisCompletedNCT019612061 country
- A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial PneumoniaTerminatedNCT01110421Phase 310 countries
- Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired PneumoniaCompletedNCT00818610Phase 41 country
- Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired PneumoniaCompletedNCT00081575Phase 3
- Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in the Paediatric A&E.CompletedNCT013967981 country
- Role of Beta-blockers in the Prevention on the Arisen of a Severe Sepsis (TESS)CompletedNCT016066311 country
- Community-acquired Pneumonia in Buskerud County in NorwayCompletedNCT015633151 country
- Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial PneumoniaTerminatedNCT01198626Phase 26 countries
- Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese SubjectsCompletedNCT00575094Phase 31 country
- New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)CompletedNCT00035269Phase 34 countries
- Tigecycline In-Vitro Surveillance Study In TaiwanCompletedNCT004883971 country
- Helmet Continuous Positive Airway Pressure Versus Oxygen Venturi in Acute Respiratory Failure in CAP: CAPOVeRSOTerminatedNCT00603564Not applicable1 country
- Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal InfectionsCompletedNCT00136201Phase 31 country
- Computerized Decision Support System for Antibiotic TreatmentCompletedNCT00233376Phase 33 countries